Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 523

Similar articles for PubMed (Select 18028219)

1.

Quantitative in vitro demonstration of two-photon photodynamic therapy using photofrin and visudyne.

Khurana M, Collins HA, Karotki A, Anderson HL, Cramb DT, Wilson BC.

Photochem Photobiol. 2007 Nov-Dec;83(6):1441-8.

PMID:
18028219
2.

Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.

Karotki A, Khurana M, Lepock JR, Wilson BC.

Photochem Photobiol. 2006 Mar-Apr;82(2):443-52.

PMID:
16613497
3.

One- and two-photon activated phototoxicity of conjugated porphyrin dimers with high two-photon absorption cross sections.

Dahlstedt E, Collins HA, Balaz M, Kuimova MK, Khurana M, Wilson BC, Phillips D, Anderson HL.

Org Biomol Chem. 2009 Mar 7;7(5):897-904. doi: 10.1039/b814792b. Epub 2009 Jan 9.

PMID:
19225672
4.

Two-photon absorption cross section of excited phthalocyanines by a femtosecond Ti-sapphire laser.

Mir Y, van Lier JE, Allard JF, Morris D, Houde D.

Photochem Photobiol Sci. 2009 Mar;8(3):391-5. doi: 10.1039/b805909h. Epub 2009 Jan 20.

PMID:
19255681
5.

Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.

Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.

Cancer Res. 2001 Aug 1;61(15):5824-32.

6.

Two-photon photodynamic therapy of C6 cells by means of 5-aminolevulinic acid induced protoporphyrin IX.

Beck TJ, Burkanas M, Bagdonas S, Krivickiene Z, Beyer W, Sroka R, Baumgartner R, Rotomskis R.

J Photochem Photobiol B. 2007 Jun 26;87(3):174-82. Epub 2007 Apr 4.

PMID:
17513121
7.

Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.

Usuda J, Tsunoda Y, Ichinose S, Ishizumi T, Ohtani K, Maehara S, Ono S, Tsutsui H, Ohira T, Okunaka T, Furukawa K, Sugimoto Y, Kato H, Ikeda N.

Lung Cancer. 2010 Feb;67(2):198-204. doi: 10.1016/j.lungcan.2009.04.002. Epub 2009 May 23.

PMID:
19477032
8.

Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells.

Banfi S, Caruso E, Caprioli S, Mazzagatti L, Canti G, Ravizza R, Gariboldi M, Monti E.

Bioorg Med Chem. 2004 Sep 15;12(18):4853-60.

PMID:
15336264
9.

Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM.

Kinzler I, Haseroth E, Hauser C, Rück A.

Photochem Photobiol Sci. 2007 Dec;6(12):1332-40. Epub 2007 Aug 6.

PMID:
18046490
10.

Drug and light dose responses to focal photodynamic therapy of single blood vessels in vivo.

Khurana M, Moriyama EH, Mariampillai A, Samkoe K, Cramb D, Wilson BC.

J Biomed Opt. 2009 Nov-Dec;14(6):064006. doi: 10.1117/1.3262521.

PMID:
20059244
11.

In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells.

Hajri A, Wack S, Meyer C, Smith MK, Leberquier C, Kedinger M, Aprahamian M.

Photochem Photobiol. 2002 Feb;75(2):140-8.

PMID:
11883602
12.

Oxygen dependence of two-photon activation of zinc and copper phthalocyanine tetrasulfonate in Jurkat cells.

Mir Y, van Lier JE, Paquette B, Houde D.

Photochem Photobiol. 2008 Sep-Oct;84(5):1182-6. doi: 10.1111/j.1751-1097.2008.00311.x. Epub 2008 Mar 7.

PMID:
18331397
13.

Photodynamic therapy: an update.

Dima VF, Vasiliu V, Dima SV.

Roum Arch Microbiol Immunol. 1998 Jul-Dec;57(3-4):207-30. Review.

PMID:
11845434
14.

Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.

Mori M, Sakata I, Hirano T, Obana A, Nakajima S, Hikida M, Kumagai T.

Jpn J Cancer Res. 2000 Jul;91(7):753-9.

PMID:
10920284
15.

Molecular determinants of photodynamic therapy for lung cancers.

Usuda J, Ichinose S, Ishizumi T, Ohtani K, Inoue T, Maehara S, Imai K, Shima K, Ohira T, Kato H, Ikeda N.

Lasers Surg Med. 2011 Sep;43(7):591-9. doi: 10.1002/lsm.21097.

PMID:
22057486
16.

Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives.

You Y, Gibson SL, Hilf R, Davies SR, Oseroff AR, Roy I, Ohulchanskyy TY, Bergey EJ, Detty MR.

J Med Chem. 2003 Aug 14;46(17):3734-47.

PMID:
12904078
17.

Effects of photodynamic therapy on adhesion molecules and metastasis.

Rousset N, Vonarx V, Eléouet S, Carré J, Kerninon E, Lajat Y, Patrice T.

J Photochem Photobiol B. 1999 Sep-Oct;52(1-3):65-73.

PMID:
10643074
18.

Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.

Garland MJ, Cassidy CM, Woolfson D, Donnelly RF.

Future Med Chem. 2009 Jul;1(4):667-91. doi: 10.4155/fmc.09.55. Review.

PMID:
21426032
19.

Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells.

Nowak-Sliwinska P, Karocki A, Elas M, Pawlak A, Stochel G, Urbanska K.

Biochem Biophys Res Commun. 2006 Oct 20;349(2):549-55. Epub 2006 Aug 22.

PMID:
16945338
20.

Relation of early Photofrin uptake to photodynamically induced phototoxicity and changes of cell volume in different cell lines.

Leunig A, Staub F, Peters J, Heimann A, Csapo C, Kempski O, Goetz AE.

Eur J Cancer. 1994;30A(1):78-83.

PMID:
8142170
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk